Robin Foà

发表

Web-based training of European hematologists

Nunzio Casalino, Alessandro D'Atri, Gina Zini, 2003 .

The Validation of the BCR/ABL1-like Predictor across Laboratories Shows Reproducibility of Results

Cyril Šálek, Robin Foà, Claudia Haferlach, 2019 .

Comprehensive Analysis of Transcriptome Variation Uncovers Known and Novel Driver Events in T-Cell Acute Lymphoblastic Leukemia

Stein Aerts, Gert Hulselmans, Frank Speleman, 2013, PLoS genetics.

Gene expression profiling identifies a subset of adult T-cell acute lymphoblastic leukemia with myeloid-like gene features and over-expression of miR-223

Robin Foà, Alessandro Fatica, Sabina Chiaretti, 2010, Haematologica.

Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways

Robin Foà, Massimo Donadelli, Marta Palmieri, 2008, Haematologica.

An international standardization programme towards the application of gene expression profiling in routine leukaemia diagnostics: the Microarray Innovations in LEukemia study prephase

Torsten Haferlach, Giuseppe Basso, Robin Foà, 2008, British journal of haematology.

Hereditary protein C deficiency and thrombosis risk: genotype and phenotype relation in a large Italian family

Robin Foà, M. Margaglione, R. Foà, 2012, European journal of haematology.

The utility of a prognostic index for predicting time to first treatment in early chronic lymphocytic leukemia: the GIMEMA experience

Agostino Cortelezzi, Vincenzo Callea, Robin Foà, 2010, Haematologica.

NK cell expression of natural cytotoxicity receptors may determine relapse risk in older AML patients undergoing immunotherapy for remission maintenance

Robin Foà, R. Foà, J. Aurelius, 2015, Oncotarget.

Tumor evolutionary directed graphs and the history of chronic lymphocytic leukemia

Luca Laurenti, Raul Rabadan, Robin Foà, 2014, eLife.

Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma.

Alessandro Corso, Robin Foà, M. Dimopoulos, 2007, The New England journal of medicine.

Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia.

Chris Sander, Mihaela Zavolan, Jingyue Ju, 2007, Blood.

NOTCH1 mutations in +12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of +12 CLL

Luca Laurenti, Robin Foà, Davide Rossi, 2012, Haematologica.

BIRC3 disruption and Copy Number Aberrations in Chronic Lymphocytic Leukemia (CLL) Patients with 11q Deletion

Robin Foà, Davide Rossi, Sabina Chiaretti, 2014 .

TRAIL decoy receptors mediate resistance of acute myeloid leukemia cells to TRAIL.

Robin Foà, Roberta Riccioni, Elvira Pelosi, 2005, Haematologica.

Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia.

Luca Laurenti, Raul Rabadan, Silvia Deaglio, 2012, Blood.

Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.

Raul Rabadan, Robin Foà, Hossein Khiabanian, 2013, Blood.

Catheter-associated bloodstream infections and thrombotic risk in hematologic patients with peripherally inserted central catheters (PICC)

Salvatore Giacomo Morano, Robin Foà, Angelo Fama, 2015, Supportive Care in Cancer.

Characterization of B‐ and T‐lineage acute lymphoblastic leukemia by integrated analysis of MicroRNA and mRNA expression profiles

Teresa Colombo, Robin Foà, Sabina Chiaretti, 2009, Genes, chromosomes & cancer.

Minimal Residual Disease in Acute Lymphoblastic Leukemia: Technical and Clinical Advances

Robin Foà, Sabina Chiaretti, R. Foà, 2019, Front. Oncol..

Gene expression profile of protein kinases reveals a distinctive signature in chronic lymphocytic leukemia and in vitro experiments support a role of second generation protein kinase inhibitors.

Robin Foà, Sabina Chiaretti, R. Foà, 2010, Leukemia research.

T-cell acute lymphoblastic leukemia

Robin Foà, Sabina Chiaretti, R. Foà, 2009, Haematologica.